Skip to main content
Download PDF

Maternal and neonatal data collection systems in low- and middle-income countries for maternal vaccines active safety surveillance systems: A scoping review

BMC Pregnancy and Childbirth volume 21, Article number: 217 (2021) Cite this article

Abstract

Background

Most post-licensure vaccine pharmacovigilance in low- and middle-income countries (LMICs) are passive reporting systems. These have limited utility for maternal immunization pharmacovigilance in LMIC settings and need to be supplemented with active surveillance. Our study’s main objective was to identify existing perinatal data collection systems in LMICs that collect individual information on maternal and neonatal health outcomes and could be developed to inform active safety surveillance of novel vaccines for use during pregnancy.

Methods

A scoping review was performed following the Arksey and O’Malley six-stage approach. We included studies describing electronic or mixed paper-electronic data collection systems in LMICs, including research networks, electronic medical records, and custom software platforms for health information systems. Medline PubMed, EMBASE, Global Health, Cochrane Library, LILACS, Bibliography of Asian Studies (BAS), and CINAHL were searched through August 2019. We also searched grey literature including through Google and websites of existing relevant perinatal data collection systems, as well as contacted authors of key studies and experts in the field to validate the information and identify additional sources of relevant unpublished information.

Results

A total of 11,817 records were identified. The full texts of 264 records describing 96 data collection systems were assessed for eligibility. Eight perinatal data collection systems met our inclusion criteria: Global Network’s Maternal Newborn Health Registry, International Network for the Demographic Evaluation of Populations and their Health; Perinatal Informatic System; Pregnancy Exposure Registry & Birth Defects Surveillance; SmartCare; Open Medical Record System; Open Smart Register Platform and District Health Information Software 2. These selected systems were qualitatively characterized according to seven different domains: governance; system design; system management; data management; data sources, outcomes and data quality.

Conclusion

This review provides a list of active maternal and neonatal data collection systems in LMICs and their characteristics as well as their outreach, strengths, and limitations. Findings could potentially help further understand where to obtain population-based high-quality information on outcomes to inform the conduct of maternal immunization active vaccine safety surveillance activities and research in LMICs.

Peer Review reports

Background

Spontaneous or passive reporting systems are a cornerstone of vaccine safety surveillance in low- and middle-income countries (LMICs) [1]. This type of reporting relies on health professionals, patients, or others reporting suspected adverse events to public health or governmental organization. These systems have several limitations, including potentially inconsistent diagnostic criteria, underreporting, varying data quality, lack of data to establish a denominator, and little or no background information [1, 2]. In of these limitations, the launch of new vaccines for immunization of pregnant women requires additional safety surveillance efforts to be in place, including active surveillance in pregnant women and newborns and other post-approval safety monitoring mechanisms. Active surveillance aims to detect adverse events on an ongoing basis within a defined group of people. It is especially useful in conjunction with the introduction of new vaccines. Using active surveillance systems, new vaccines in development for maternal immunization (e.g., respiratory syncytial virus (RSV), group B streptococcus (GBS) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could achieve their main goal of reducing morbidity and mortality in newborns in an informed manner [3]. Traditionally, active surveillance systems in LMIC have been linked to the Expanded Program on Immunization (EPI) and primarily focused on pediatric vaccines administered to children. For the evaluation of vaccine safety in pregnant women, maternal and neonatal data collection systems need to be leveraged to provide knowledge on background rates of pregnancy outcomes and newborn events. In the absence of an accurate background rate of an event, it is impossible to know if the adverse event is occurring at an expected or higher than expected rate. Having an established background rate would be further helpful for informing policies and designing active vaccine safety surveillance studies at sentinel sites [4, 5]. Perinatal outcomes information is generally unavailable in LMICs, due to many reasons, including the scarcity of resources and trained staff to support robust data collection systems, occurrence of vital and clinical events outside medical facilities, the lack of standardized, comprehensive, national registers and registration systems, inconsistencies among maternal newborn health outcome definitions, and the fact that medical records are often incomplete, poorly maintained and only paper based [1, 2, 6]. Lack of these records makes linking individual data from mother and their babies across systems cumbersome or sometimes impossible.

The Global Alignment of Immunization Safety Assessment in pregnancy (GAIA) project defined case definitions for main MNCH outcomes [7]. However, no sustainable answers are available on feasibility to implement them in the field [5, 7]. Various population-based surveys, surveillance systems, health information systems and perinatal data collection systems are already in place and could provide information on maternal and infant health in low-resource settings [8]. Mapping and harmonizing these existing platforms would allow LMICs to increase their ability to monitor relevant MNCH outcomes following maternal immunization.

There is an urgent need to develop or improve active safety surveillance of novel vaccines in pregnancy by understanding and adapting existing MNCH data collection systems. As part of a landscape analysis for integrated maternal immunization active safety surveillance and maternal data collection systems in LMICs, a scoping review was conducted to identify existing electronic and mixed paper-electronic data collection systems that register continuous and individual level MNCH data in LMICs with the potential to provide background data on diseases as well as record MNCH events/outcomes for active safety surveillance for novel maternal vaccines.

Methods

We included studies describing electronic or mixed paper-electronic data collection systems in LMICs, including research networks, electronic medical records, and custom software platforms for health information systems. Medline PubMed, EMBASE, Global Health, Cochrane Library, LILACS, Bibliography of Asian Studies (BAS), and CINAHL were searched through August 2019. We also searched grey literature including through Google and websites of existing relevant perinatal data collection systems, as well as contacted authors of key studies and experts in the field to validate information and identify additional sources of relevant unpublished information.

We performed a scoping review following the Arksey and O’Malley six-stage approach [9] and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines and its extension for scoping reviews [10] (Additional file 1). The scoping review protocol was previously published in the Gates Open Research Journal [11].

Two main research questions guided the scoping review:

  • What existing prenatal and postnatal data collection systems are in place at the facility level and community level that could provide continuous, longitudinal, and individual information on maternal and neonatal health outcomes in LMICs?

  • Do existing prenatal and postnatal data collection systems have the capacity to inform active safety surveillance for maternal vaccines and other maternal health interventions?

Studies describing electronic or mixed paper-electronic perinatal data collection systems in LMICs, including research networks, electronic medical records, and custom software platforms for health information systems were included. Search strategies were run in databases (Medline, PubMed, EMBASE, Global Health, Cochrane Library, LILACS, Bibliography of Asian Studies (BAS), and CINAHL) and Google through August 2019. Grey literature including websites of existing data collection systems were explored [11].

The PRISMA Extension for Scoping Reviews (PRISMA-ScR) flow diagram represents the formal literature review and screening process developed (Fig. 1). From those perinatal data collection systems identified in the full text article review, all specific data points published in the protocol [11] and listed in Table 1 were recorded.

Fig. 1
figure 1

The PRISMA flow diagram details the selection process applied during the systematic literature search and review.

Full size image
Table 1 Data points abstracted from selected studies [11].
Full size table

A modified framework to assess and describe the final identified existing MNCH eligible health systems attributes was used based on frameworks available in the literature [12,13,14]. Governance; System design; Data management; Data sources, Outcomes and Data quality are the six domains used to present the extracted data points (Table 2).

Table 2 Framework: domains used to present the extracted data points
Full size table

The objectives of the consultation phase were to share preliminary findings and comparative analysis of final list of systems with experts in order to validate the domains used to describe the systems (Table 2) and the extracted data points (Table 1) from each system, as well as to identify additional grey sources of information.

Results

Study selection and characteristics

A total of 11,817 records including additional sources from reference lists and grey literature were identified. After removing duplicates, the 8,069 records left were screened by title and abstract, and 7,805 were considered irrelevant mainly because they were not related to MNCH data collection systems in LMICs. The full texts of 264 records describing 96 data collection systems were assessed for eligibility and finally, eight perinatal data collection systems (involving 165 reports) were included in qualitative synthesis (Figure 1). The included 165 reports were categorized as descriptive articles (51 published and 12 unpublished), published research studies related to the data collection systems (n=87), official system websites (n=7), user manuals or guides (n=3), and other web links that were not official systems websites (n=5). The most frequent reasons for excluding 99 reports were not collecting perinatal outcomes continuously at the individual-level (64), not currently capturing data (12) or not being a specific MNCH data collection system (9). The reasons for final exclusions of the potentially eligible systems are presented in Additional file 3.

The eight data collection systems finally selected were: 1) Global Network’s Maternal Newborn Health Registry (GN-MNHR), 2) International Network for the Demographic Evaluation of Populations and their Health (INDEPTH), 3) Perinatal Informatic System (SIP), 4) Pregnancy Exposure Registry & Birth Defects Surveillance (PER/BDS), 5) SmartCare, 6) Open Medical Record System (OpenMRS), 7) Open Smart Register Platform (OpenSRP) and 8) District Health Information Software 2 (DHIS 2) (see Table 3).

Table 3 Included data collection systems
Full size table

Regarding the geographic distribution of the systems, although they were implemented in many different countries and districts, not all sites captured individual maternal and neonatal data. Therefore, we only included the sites that met the objectives and inclusion criteria of our study. DHIS 2 tracker, GN-MHNR and INDEPTH are in sub-Sahara Africa and South Asia. Additionally, GN-MNHR is also located in Latin America and the Caribbean (Guatemala), DHIS 2 is in the Middle East and North Africa (West Bank and Gaza), and INDEPTH is in East Asia and the Pacific (Indonesia, Malaysia and Vietnam). PER/BDS is located only in South Africa. SmartCare is in Zambia and OpenSRP is in Indonesia and Pakistan. Finally, OpenMRS is located in Uganda, Rwanda, Lesotho, Malawi, Kenya and Haiti.

Out of the 165 included reports: 86 (52.1%) were related to INDEPTH [16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101], 26 (15.7%) to Global Network [102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127], 24 (14.5%) to DHIS 2 [128,129,130,131,132,133,134,135,136,137,138,139,140,141,142,143,144,145,146,147,148,149,150,151], 9 (5.4%) to OpenMRS [152,153,154,155,156,157,158,159,160], 6 (3.6%) to SIP [161,162,163,164,165,166], 6 (3.6%) to OpenSRP [167,168,169,170,171,172], 4 (2.4%) to PER/BDS [173,174,175,176], and 4 (2.4%) to SmartCare [177,178,179,180].

Major findings by identified domain

Following the analysis of the extracted data, the eight included systems’ synthetized results were presented in seven domains: Governance; System design; System management; Data management; Data sources, Outcomes and Data quality (Tables 4, 5, 6, 7, 8 and 9). Extracted data has been made available in a web-interactive App: http://safeinpregnancy.org/la_sc/table_by_domain.html#.

Table 4 Governance
Full size table
Table 5 System design
Full size table
Table 6 Data management
Full size table
Table 7 Data sources
Full size table
Table 8 Maternal outcomes
Full size table
Table 9 Maternal outcomes
Full size table

Governance (Table 4)

These systems are supported by different categories of institutions [181] such as private foundations (e.g., Bill and Melinda Gates Foundation, Wellcome Trust, The Rockefeller Foundation, Children’s Investment Fund Foundation, Hewlett Foundation), governmental agencies in high-income countries (e.g., United States Agency for International Development (USAID), Centers for Disease Control and Prevention, Norad), global health initiatives (President’s Emergency Plan For AIDS Relief, The Global Alliance for Vaccines and Immunization), research councils (National Institutes of Health, National Institute of Child Health and Human Development, Medical Research Council), non-governmental organizations (Comic Relief), international organizations (World Health Organization /Pan America Health Organization, UNICEF), universities (Harvard University, University of Oslo), private sector organizations (GlaxoSmithKline, Qualcomm) and LMIC governments (South Africa National Department of Health) [14, 17, 37, 77, 103, 161, 178].

Some organizations were also responsible for the development and implementation of the included systems and are responsible for its optimal operability, such as the University of Oslo in the case of DHIS 2 [131], Partners in Health for OpenMRS [152], WHO for OpenSRP [170] and National Department of Health South Africa for PER/BDS [182] (Table 4). The majority of the systems demonstrated features that support the protection and privacy of collected information through anonymization of data, implementation of passwords before access, or external security (cybersecurity) [38, 77, 103, 131, 141, 154, 170, 177, 179]. Up to the search date, neither GN-MNHR nor SIP allowed for data encryption.

We were able to access the operating manuals, data forms, and documentation for six out of the eight systems [17, 103, 131, 152, 163, 170]; for SmartCare and PER/BDS these types of documents were not identified. Although most of the systems were designed for clinical care, some had been conceptualized for research such as GN-MNHR [106, 113, 119, 122, 123] or surveillance such as INDEPTH [46, 49, 77, 100] or PER/BDS [174]. Some of these were designed to satisfy more than one objective, and in the case of OpenMRS, this varied in different locations where the system is in place [130, 145, 152, 161, 170, 178].

System design (Table 5)

The type of license was free and open-source for four systems: DHIS 2 [131, 140], OpenSRP [170], OpenMRS [156] and PER/BDS [182]. SIP used a closed-code source [161] and GN-MNHR used a private license. Web-based platforms were the most frequently used [46, 49, 131, 140, 153, 156, 170]. However, the two systems GN-MNHR [103] and SIP [161, 163] still used local networks. No information on the type of license was recorded on SmartCare and INDEPTH.

Interoperability was assessed through the system’s ability to compile, transfer and export data, and integrate with other data sources, systems, individual and laboratory records, and/or national health record databases. The DHIS 2 [131, 132, 145, 146, 148], INDEPTH [17, 18, 21, 28, 35,36,37,38, 46, 58, 97, 100], SmartCare [177,178,179,180], OpenMRS [153, 154], OpenSRP [171] and PER/BDS [174] all have these capabilities. GN-MNHR [103, 108] and SIP [161, 163] systems showed lack of ability to link with National Health databases and clinical or laboratory records. All eight data collection systems demonstrated flexibility to add new variables.

Data were captured only at facilities in the system SIP [161], SmartCare [178] and PER/BDS [174, 182]. Data were captured both at the facility and community level for the systems DHIS 2 [144, 148], INDEPTH [49, 100], OpenMRS [152,153,154] and OpenSRP [170]. GD-MNHR only captured data at the community level [108, 113]. GD-MNHR only captured data at the community level [17, 33, 109, 123, 130, 131].

Data management (Table 6)

Although all of the included systems recorded data electronically [28, 49, 62, 85, 100, 108, 141, 145, 150, 152, 161, 169] and SmartCare [178, 179], used a mixed modality and initially captured data only on paper. Trained health providers, including nurses and doctors, collected the data in all systems. Only the DHIS 2 system through the MomConnect platform [140] allows pregnant women to enter information directly into the system through their smartphones. OpenSRP promotes a mobile health platform that allows health workers to register and track patient data [167].

GN-MNHR, INDEPTH, PER/BDS and SIP coordinated the data collection and validation across the sites [17, 103, 161, 182]. In contrast, DHIS 2, OpenMRS , OpenSRP and SmartCare offered a module and platform that each site can customize, modify, and adapt for use with total autonomy [131, 152, 170, 178].

The tenth revision of the International Classification of Diseases (ICD10) was used to code outcomes and conditions by more than half of the systems: DHIS 2 [130, 131], INDEPTH [100], OpenMRS [154], SIP [161] and PER/BDS [176]. No information was found regarding how OpenSRP and SmartCare systems classified and coded outcomes. The GN-MNHR system does not use any standardized classification. Only INDEPTH had been used for phase IV safety trials and post-marketing surveillance by a maternal health research platform [17, 183].

Data sources (Table 7)

All the systems can collect patient data and longitudinally track pregnant women’ progress and their babies over the prenatal and postnatal periods. However, timing of capturing information from antenatal visits is different between the eight systems. GN-MNHR and INDEPTH collected antenatal care data retrospectively [17, 103]. GN-MNHR collected their data at enrollment and delivery [103], and INDEPTH collected past events by self-reported data from household visits [17].

Drug exposures during pregnancy were recorded widely (e.g., antimalarial and antiretroviral treatment, iron, folic acid and vitamins) [17, 68, 103, 114, 127, 150, 152, 165, 170, 178, 182]. Exposure to vaccines was also collected, mainly of certain vaccines related to pregnancy (Influenza, tetanus/pentavalent) as well as non-pregnancy related vaccines (Hepatitis B, BCG, Haemophilus influenzae type B) [17, 68, 103, 114, 127, 130, 152, 165, 170, 178, 182]. PER/BDS system showed the widest drug and vaccine exposure recording, and intends to increase the list during the registry’ s future national implementation [174, 175]. We did not find information about collecting this information for SmartCare.

Maternal and neonatal outcomes (Tables 8 and 9)

Twenty-nine MNCH outcomes in selected data collection systems were searched: 16 maternal outcomes and 13 neonatal outcomes. We did not find information about SmartCare regarding their recorded perinatal outcomes.

All systems collected vital data such as maternal and neonatal deaths. The most frequently recorded perinatal outcomes were fetal distress, postpartum hemorrhage, antenatal bleeding, dysfunctional labor, spontaneous abortion, congenital anomalies, neonatal infections, preterm birth, stillbirth, low birth weight, small for gestational age and respiratory distress. Some outcomes were not recorded by any of the selected systems, i.e., premature preterm rupture of membranes, preterm labor, insufficient cervix and neurodevelopmental delay [184].

The seven systems with available data recorded 13 to 22 perinatal outcomes out of a total of 29 perinatal outcomes. Of the 16 maternal outcomes evaluated, SIP [161, 163, 165] and GN-MNHR [108, 110, 113, 119, 122] registered more than 50% of outcomes (n=11 and n=10 respectively) , DHIS 2 [131, 142, 150], OpenMRS [154] and OpenSRP [168,169,170] registered 50% of outcomes (n=8 each) and INDEPTH [38, 46, 49, 68, 77, 100] and PER/BDS [182] less than 50% of outcomes (n=6 each).

Of the 13 neonatal outcomes evaluated, SIP [161, 165], PER/BDS [175], GN-MNHR [105, 106, 108, 113, 114, 119], DHIS 2 [138, 145, 146, 150] and INDEPHT [38, 46, 49, 56, 68, 100] registered more than 50%, (n=11, n=11, n=10, n=9 and n=7 respectively) and OpenMRS [152, 154] and OpenSRP [169, 170] less than 50% (n=6 and n=5 outcomes, respectively).

Data quality (Table 10)

This domain was evaluated by examining information on both external and internal quality control mechanisms used by data collection systems. Internal monitoring was the most frequently cited procedure, specifically pre-programmed checks to avoid incorrect data entry [29, 38, 103, 139, 152, 156, 170]. Regarding external monitoring, only half of the systems reported having the necessary structures to be subject to frequent auditing and manual reporting [28, 38, 45, 108, 113, 145]. Only three systems demonstrated internal and external quality controls (DHIS 2, GN-MNHR and INDEPTH).

Table 10 Data Quality
Full size table

Discussion

Through the present scoping review, 8,069 records were screened, and eight active data collection systems were identified. These systems continuously collect individual maternal and neonatal data in LMICs that can be leveraged for active safety surveillance of novel maternal vaccines.

Among the eight systems, seven systems are being used in countries in Africa, four in Asia and three in Latin America. Data collection systems served as research networks, perinatal electronic medical records, or a custom software platform for health information systems. The eight data collection systems showed variability regarding their governance, system design, data management, data sources, outcomes collected and data quality. Among these systems, all except SIP protected privacy of the information collected through anonymization of data. All systems except for GN-MNHR and SIP demonstrated interoperability capabilities and used web-based platforms. Data were recorded from antenatal care to postnatal period in all systems; however, GN-MNHR and INDEPTH collected antenatal visits data retrospectively. All systems collected vital data such as maternal and neonatal deaths as well as recorded exposure to vaccines and drugs during pregnancy. The most frequently recorded perinatal outcomes were fetal distress, postpartum hemorrhage, antenatal bleeding, dysfunctional labor, spontaneous abortion, congenital anomalies, neonatal infections, preterm birth, stillbirth abortion, low birth weight, small for gestational age, respiratory distress and failure to thrive, with variability among the systems. Any of the selected systems did not record the outcomes premature preterm rupture of membranes, preterm labor, insufficient cervix, and neurodevelopmental delay. GN-MNHR and INDEPTH coordinated the data collection and validation across their sites. In contrast, the rest of the systems offered a module and open-source platform that each site can customize, modify, and adapt for use with total autonomy. The tenth revision of the International Classification of Diseases (ICD10) was used for coding outcomes and conditions by DHIS 2, INDEPTH, OpenMRS, SIP and PER/BDS. No information was found on how outcomes and conditions were coded for the systems OpenSRP and SmartCare. As far as we know, GN-MNHR system does not use any standardized classification.

One close antecedent to our study is the work published by Froen et al., who, using WHO frameworks, mapped electronic registries (eRegistries) for maternal and child health [185]. The authors conducted a web-based survey of public health officials in LMICs and a search of literature from 2005 to 2015 to assess country capacity, quality and data usage in reproductive health registries. Froen et al. found 32 paper and electronic registry systems in 23 countries, supporting commonly used electronic and mobile applications for health. During those years, countries were in transition from paper-based data collection to electronic systems but very few have integrated electronic backbone systems. A more detailed framework was used to assess and describe the existing and eligible attributes of MNCH health systems, focusing on electronic data collection systems [12]. Our broad search conducted in August 2019 identified three times the number of registries (n=96). In contrast with their findings, we assessed that only eight were proficient in informing active safety vaccine surveillance system.

Zuber and colleagues [7] created a map of MNCH initiatives that collected health information to monitor maternal and child interventions in LMICs. The reported programs collected maternal and child health aggregate data and were fragmented in governance and financing and were duplicated in several related initiatives. They could not link individual-level data from pregnant women and their offspring including the linkage across individual records and multiple registers and sources. An active safety surveillance system for maternal vaccines would require statistics and monitoring of health data that reflect mother-baby dyad, characteristics, conditions and events from pregnancy to childbirth and postpartum care collected systematically, longitudinal, individual and uniform way. Our findings demonstrate that there are at least eight existing types of perinatal data collection systems/platforms implemented successfully in LMICS and can scale-up and collect MNCH individual-level data that track mothers and their babies.

Post-marketing surveillance of drugs used during pregnancy have been carried out in LMICs. Particularly, during the dolutegravir surveillance in Botswana (2018), 134 congenital abnormalities were identified in pregnant women exposed to this drug. Of these, the majority (104 cases) came from post-marketing studies, and only a few from spontaneous reports. However, although reporting post-marketing surveillance is useful, it lacks the ability to calculate prevalence rates because the true denominator is not usually available and births without defects are also underreported in LMICs frequently [186]. Another example, the International Maternal Pediatric Adolescents AIDS Clinical Trials (IMPAACT) network has been conducting clinical trials of drugs used during pregnancy with the aim of reducing perinatal transmission of human immunodeficiency virus. Some of them were phase IV trials and have provided important information during post-marketing stage. However, as limitation of those studies and as with most clinical trials data collection systems, some conclusions obtained might not be entirely extrapolated to the real world, and very low incidence adverse effects might not be detected in them [187]. Concerning antimalarial surveillance, a prospective observational study using HDSS (INDEPTH system) conducted in Burkina Faso, Kenya and Mozambique has evaluated artemisinin exposure and monitoring in pregnant women. Although the methods described and used in this study have been relevant in the development of pharmacovigilance of drugs in pregnancy and baseline perinatal prevalence rates might be measured in the regions, they have had certain limitations in quality and feasibility to collect certain outcomes. With the exception of the Kenya site where active surveillance has been carried out, in the other sites it was not possible to detect early miscarriages as well as the early identification of pregnancy [98].

The main strengths of our study are that we followed established methods [9, 188], utilized an exhaustive search strategy that included an in-depth grey literature search, and consulted large group of experts in the field with experience in pharmacovigilance, vaccine safety monitoring, as well as MNCH in LMICs on the results of this review.

The study’s main limitations are the heterogeneous and incomplete available reporting, forcing us to look for multiple non-peer-reviewed reports and directly contact authors and data system authorities to obtain a complete picture of each system. On-site visits and interviews to key referents could improve the completeness of this information, although these methods were beyond the scope of our protocol. For example, quality of data, capacity for data sharing and prevalence of maternal and infant health outcomes in each site from each system could also be obtained during future site visits in order to supplement the findings of this review.

Another limitation of our study is related to the definitions of maternal and neonatal outcomes that each system reported as being measured. The GAIA case definitions were used as a guide in order to ensure extracting all relevant perinatal data outcomes. Due to the fact that many of these GAIA definitions are really complex and require a lot of information to be considered as correctly defined, we cannot affirm that the full case definitions in each system comply exactly with the parameters proposed by GAIA [184].

Our findings have important implications not only for safety surveillance in maternal vaccines but also for policymakers and other stakeholders committed to research in MNCH. The analytical framework used demonstrated that all of the data collection systems identified in LMICs showed strengths and weaknesses to varying extents. However, several of the data collection systems are ready to inform future active safety surveillance. Regarding data protection, although most LMICs have not adopted a specific legislation or a Data Protection Authority [15], seven out of eight systems in this review included an appropriate data protection process to protect personal information about women and their children to be used, intentionally or otherwise, for purposes other than understanding and informing the prevention of poor health outcomes or to measure the safety of vaccines. Variability in case definitions and diagnostic criteria across data sources, and among differing cultures and languages was presented as a challenge by experts. Lack of harmonization of case confirmation/classification among systems was also a defined problem in LMICs [7, 189]. However, among the eight data collection systems found in our review, seven used the International Classification of Diseases (ICD) codes for standardized reporting of diseases. This is a promising finding to advance the integration and harmonization of the collection of MNCH data across systems in LMICs. Further in-depth exploration of these systems will provide more details about their capacity.

Our work could help to recognize and overcome the highlighted knowledge gap regarding the existence and capacity of surveillance platforms in LMICs for novel maternal vaccines. Identifying individual MNCH data platforms for pregnancy and disease surveillance is the first key action needed to identify potential sentinel sites for implementing integrated active surveillance successfully.

Conclusion

We present a list of existing MNCH data capture systems in LMICs and describe in detail their characteristics, outreach, strengths, and limitations. This knowledge could potentially help policymakers, vaccine developers, researchers, and regulators to understand where to obtain population-based high-quality information on outcomes to inform and improve the conduct of vaccine active safety surveillance in LMICs.

Availability of data and materials

All data generated or analyzed during this study are included in this published article and its supplementary information files.

Abbreviations

LMICS:

Low- and middle-income countries

MNCH:

Maternal neonatal and child health

GAIA:

Global Alignment of Immunization Safety Assessment in pregnancy

WHO:

World Health Organization

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

GAVI:

Global Alliance for Vaccines and Immunization

GN-MNHR:

Global Network’s Maternal Newborn Health Registry

INDEPTH:

International Network for Demographic Evaluation of Populations and their Health

SIP:

Perinatal Informatic System

PER/BDS:

Pregnancy Exposure Registry & Birth Defects Surveillance

OpenMRS:

Open Medical Record System

OpenSRP:

Open Smart Register Platform

DHIS 2:

District Health Information Software 2

ICD10:

The tenth revision of the International Classification of Diseases

References

  1. GAPPS. Maternal Immunization Safety Monitoring In Low- and- Middle-income Countries: A Roadmap For Program Development. Global Alliance to Prevent Prematurity and Stillbirth. 2017. https://www.gapps.org/PDF/MaternalImmunizationSafetyMonitoringInLMICs.pdf. Accessed 19 May 2020.

  2. Lackritz E, Stepanchak M: Maternal Immunization Safety Monitoring in Low- and Middle-Income Countries: A Roadmap for Program Development. 2017. https://www.gapps.org/PDF/MaternalImmunizationSafetyMonitoringInLMICs.pdf. Accessed 3 July 2020.

  3. Engmann C, Fleming JA, Khan S, Innis BL, Smith JM, Hombach J, Sobanjo-Ter Meulen A. Closer and closer? Maternal immunization: current promise, future horizons. J Perinatol. 2020;40(6):844–57.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Jones CE, Munoz FM, Spiegel HM, Heininger U, Zuber PL, Edwards KM, Lambach P, Neels P, Kohl KS, Gidudu J, et al. Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women. Vaccine. 2016;34(49):5998–6006.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kochhar S, Bonhoeffer J, Jones CE, Muñoz FM, Honrado A, Bauwens J, Sobanjo-Ter Meulen A, Hirschfeld S. Immunization in pregnancy clinical research in low- and middle-income countries - Study design, regulatory and safety considerations. Vaccine. 2017;35(48 Pt A):6575–81.

    Article  PubMed  PubMed Central  Google Scholar 

  6. MCSP: What Data on Maternal and Newborn Health Do National Health Management Information Systems Include? 2018. https://www.mcsprogram.org/. Accesed 20 July 2020.

    Google Scholar 

  7. Zuber PLF, Moran AC, Chou D, Renaud F, Halleux C, Peña-Rosas JP, Viswanathan K, Lackritz E, Jakob R, Mason E, et al. Mapping the landscape of global programmes to evaluate health interventions in pregnancy: the need for harmonised approaches, standards and tools. BMJ Glob Health. 2018;3(5):e001053.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sobanjo-Ter Meulen A, Munoz FM, Kaslow DC, Klugman KP, Omer SB, Vora P, Stergachis A. Maternal interventions vigilance harmonization in low- and middle-income countries: Stakeholder meeting report; Amsterdam, May 1-2, 2018. Vaccine. 2019;37(20):2643–50.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.

    Article  Google Scholar 

  10. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73.

    Article  PubMed  Google Scholar 

  11. Berrueta M, Bardach A, Ciaponni A et al. Maternal and neonatal data collection systems in low- and middle-income countries: scoping review protocol [version 1; peer review: 3 approved]. Gates Open Res. 2020;4:18.

  12. MEASURE Evaluation. Strengthening Health Information Systems in Low- and Middle-Income Countries A Model to Frame What We Know and What We Need to Learn. Chapel Hill: MEASURE Evaluation; 2019.

    Google Scholar 

  13. Health Metrics N, World Health O. Framework and standards for country health information systems. 2nd ed. Geneva: World Health Organization; 2008. https://apps.who.int/iris/handle/10665/43872. Accessed 1 June 2020

    Google Scholar 

  14. Dawne W: Model of a Community-Based Information System: Essential Components and Functions. 2018. https://www.measureevaluation.org/. Accessed 20 May 2020.

    Google Scholar 

  15. Commission Nationale de l'Informatique et des Libertés . Data protection around the world. 2020. https://www.cnil.fr/en/data-protection-around-the-world. Accessed 19 June 2020.

  16. Monitoring and assessing the impact of vaccination and other childhood interventions for both boys and girls. 2017. https://dfcentre.com/wp-content/uploads/2017/07/09-105SSI-App-3b-Policy-Brief.pdf. Accessed 19 June 2020.

  17. INDEPTH Network. http://www.indepth-network.org/. Accessed 20 May 2020.

  18. Bardaji A, Tembe N, Mucavele H, Massora S, Aguado T, Bassat Q, Macete E, Menéndez C: Research capacities at ISGlobal to conduct vaccine trials and clinical studies in support to maternal immunization research in Mozambique. In: 5th International Neonatal & Maternal Immunization Symposium. Vancouver; 2019.

  19. Dure Technology: Overview of the nutrition information system in Lao PDR. In. Montpellier: Agropolis International. 2019. http://www.nipn-nutrition-platforms.org/. Accessed 19 June 2020.

  20. Duthé G: The impact of the marital status of the mother at birth on the mortality risks during childhood in rural Senegal: a gender perspective. In: PAA Annual meeting. Chicago; 2017.

  21. Haile D, Kondale M, Andarge E, Tunje A, Fikadu T, Boti N. Level of completion along continuum of care for maternal and child health services and factors associated with it among women in Arba Minch Zuria Woreda, Gamo Zone, Southern Ethiopia: a community based cross-sectional study. PLoS One. 2020;15(6):e0221670.

  22. Lankoande YB, Pison G: Does pregnancy follow up improve reliability of under five mortality estimates in Health and Demographic Surveillance Systems? Insights from Bandafassi and Niakhar (Senegal). In: 8th African Population Conference. Entebbe; 2019. http://uaps2019.popconf.org/abstracts/190752.

  23. Nurul A, Chowdhury H, Das S, Ali A, Streatfield P. Causes of death in two rural demographic surveillance sites in Bangladesh, 2004-2010: automated coding of verbal autopsies using InterVA-4. (Special Issue: INDEPTH network cause-specific mortality.). Global Health Action. 2014;7:25511 32 ref 2014.

    Article  Google Scholar 

  24. Olatunji A, Doctor HV. The Potential Role of a Health and Demographic Surveillance System in Rural Northern Nigeria to Reduce Maternal and Child Deaths. Health. 2014;7(12):1741–6.

    Google Scholar 

  25. Afework MF, Gebregiorgis SH, Roro MA, Lemma AM, Ahmed S. Do Health and Demographic Surveillance Systems benefit local populations? Maternal care utilisation in Butajira HDSS, Ethiopia. Glob Health Action. 2014;7:24228.

    Article  PubMed  Google Scholar 

  26. Alabi O, Doctor HV, Afenyadu GY, Findley SE. Lessons learned from setting up the Nahuche Health and Demographic Surveillance System in the resource-constrained context of northern Nigeria. Glob Health Action. 2014;7:23368.

    Article  PubMed  Google Scholar 

  27. Alabi O, Doctor HV, Jumare A, Sahabi N, Abdulwahab A, Findley SE, Abubakar SD. Health & demographic surveillance system profile: the Nahuche Health and Demographic Surveillance System, Northern Nigeria (Nahuche HDSS). Int J Epidemiol. 2014;43(6):1770–80.

    Article  PubMed  Google Scholar 

  28. Alam N, Ali T, Razzaque A, Rahman M, Zahirul Haq M, Saha SK, Ahmed A, Sarder AM, Moinuddin Haider M, Yunus M, et al. Health and Demographic Surveillance System (HDSS) in Matlab, Bangladesh. Int J Epidemiol. 2017;46(3):809–16.

    Article  PubMed  Google Scholar 

  29. Alam N, Townend J. The neighbourhood method for measuring differences in maternal mortality, infant mortality and other rare demographic events. Plos One. 2014;9(1):e83590.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Alberts M, Dikotope SA, Choma SR, Masemola ML, Modjadji SE, Mashinya F, Burger S, Cook I, Brits SJ, Byass P. Health & Demographic Surveillance System Profile: The Dikgale Health and Demographic Surveillance System. Int J Epidemiol. 2015;44(5):1565–71.

    Article  PubMed  Google Scholar 

  31. Amek NO, Odhiambo FO, Khagayi S, Moige H, Orwa G, Hamel MJ, Van Eijk A, Vulule J, Slutsker L, Laserson KF. Childhood cause-specific mortality in rural Western Kenya: application of the InterVA-4 model. Glob Health Action. 2014;7:25581.

    Article  PubMed  Google Scholar 

  32. Aponte JJ, Aide P, Renom M, Mandomando I, Bassat Q, Sacarlal J, Manaca MN, Lafuente S, Barbosa A, Leach A, et al. Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet. 2007;370(9598):1543–51.

    Article  CAS  PubMed  Google Scholar 

  33. Arikpo I, Okoro A, Esu E, Aquaisua E, Ekinya I, Meremikwu M. Differences in Population Dynamics and Uptake of Reproductive Health Services in the Urban and Rural Cohorts of Cross River Health and Demographic Surveillance System of Southern Nigeria. Developing Country Studies. 2019;9:64–71.

  34. Arnaldo P, Rovira-Vallbona E, Langa JS, Salvador C, Guetens P, Chiheb D, Xavier B, Kestens L, Enosse SM, Rosanas-Urgell A. Uptake of intermittent preventive treatment and pregnancy outcomes: health facilities and community surveys in Chókwè district, southern Mozambique. Malar J. 2018;17(1):109.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Assefa N, Lakew Y, Belay B, Kedir H, Zelalem D, Baraki N, Damena M, Oljira L, Ashenafi W, Dedefo M. Neonatal mortality and causes of death in Kersa Health and Demographic Surveillance System (Kersa HDSS), Ethiopia, 2008-2013. Matern Health Neonatol Perinatol. 2016;2:7.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Assefa N, Oljira L, Baraki N, Demena M, Zelalem D, Ashenafi W, Dedefo M. HDSS Profile: The Kersa Health and Demographic Surveillance System. Int J Epidemiol. 2016;45(1):94–101.

    Article  PubMed  Google Scholar 

  37. Assefa N, Semahegn A. Fertility is below replacement in Harar Health and Demographic Surveillance System (Harar HDSS), Harar town, Eastern Ethiopia. Fertil Res Pract. 2016;2:10.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Baschieri A, Gordeev VS, Akuze J, Kwesiga D, Blencowe H, Cousens S, Waiswa P, Fisker AB, Thysen SM. Rodrigues A et al: “Every Newborn-INDEPTH” (EN-INDEPTH) study protocol for a randomised comparison of household survey modules for measuring stillbirths and neonatal deaths in five Health and Demographic Surveillance sites. J Glob Health. 2019;9(1):010901.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Bawah A, Houle B, Alam N, Razzaque A, Streatfield PK, Debpuur C, Welaga P, Oduro A, Hodgson A, Tollman S, et al. The Evolving Demographic and Health Transition in Four Low- and Middle-Income Countries: Evidence from Four Sites in the INDEPTH Network of Longitudinal Health and Demographic Surveillance Systems. Plos One. 2016;11(6):e0157281.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Becher H, Müller O, Dambach P, Gabrysch S, Niamba L, Sankoh O, Simboro S, Schoeps A, Stieglbauer G, Yé Y, et al. Decreasing child mortality, spatial clustering and decreasing disparity in North-Western Burkina Faso. Trop Med Int Health. 2016;21(4):546–55.

    Article  PubMed  Google Scholar 

  41. Bocoum FY, Tarnagda G, Bationo F, Savadogo JR, Nacro S, Kouanda S, Zarowsky C. Introducing onsite antenatal syphilis screening in Burkina Faso: implementation and evaluation of a feasibility intervention tailored to a local context. BMC Health Serv Res. 2017;17(1):378.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Bogale TN, Worku AG, Bikis GA, Kebede ZT. Why gone too soon? Examining social determinants of neonatal deaths in northwest Ethiopia using the three delay model approach. BMC Pediatr. 2017;17(1):216.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Coates MM, Kamanda M, Kintu A, Arikpo I, Chauque A, Mengesha MM, Price AJ, Sifuna P, Wamukoya M, Sacoor CN, et al. A comparison of all-cause and cause-specific mortality by household socioeconomic status across seven INDEPTH network health and demographic surveillance systems in sub-Saharan Africa. Glob Health Action. 2019;12(1):1608013.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Crampin AC, Dube A, Mboma S, Price A, Chihana M, Jahn A, Baschieri A, Molesworth A, Mwaiyeghele E, Branson K, et al. Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol. 2012;41(3):676–85.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Cunningham SA, Shaikh NI, Nhacolo A, Raghunathan PL, Kotloff K, Naser AM, Mengesha MM, Adedini SA, Misore T, Onuwchekwa UU, et al. Health and Demographic Surveillance Systems Within the Child Health and Mortality Prevention Surveillance Network. Clin Infect Dis. 2019;69(Suppl 4):S274–s279.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Delaunay V, Douillot L, Diallo A, Dione D, Trape JF, Medianikov O, Raoult D, Sokhna C. Profile: the Niakhar Health and Demographic Surveillance System. Int J Epidemiol. 2013;42(4):1002–11.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Deribew A, Ojal J, Karia B, Bauni E, Oteinde M. Under-five mortality rate variation between the Health and Demographic Surveillance System (HDSS) and Demographic and Health Survey (DHS) approaches. BMC Public Health. 2016;16(1):1118.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Derra K, Rouamba E, Kazienga A, Ouedraogo S, Tahita MC, Sorgho H, Valea I, Tinto H. Profile: Nanoro Health and Demographic Surveillance System. Int J Epidemiol. 2012;41(5):1293–301.

    Article  PubMed  Google Scholar 

  49. Derso T, Biks GA, Tariku A, Tebeje NB, Gizaw Z, Muchie KF, Shimeka A, Kebede Y, Abebe SM, Yitayal M, et al. Correlates of early neonatal feeding practice in Dabat HDSS site, northwest Ethiopia. Int Breastfeed J. 2017;12:25.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Derso T, Tariku A, Biks GA, Wassie MM. Stunting, wasting and associated factors among children aged 6-24 months in Dabat health and demographic surveillance system site: A community based cross-sectional study in Ethiopia. BMC Pediatr. 2017;17(1):96.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Fekadu A, Yitayal M, Alemayehu GA, Abebe SM, Ayele TA, Tariku A, Andargie G, Teshome DF, Gelaye KA. Frequent Antenatal Care Visits Increase Institutional Delivery at Dabat Health and Demographic Surveillance System Site, Northwest Ethiopia. J Pregnancy. 2019;2019:1690986.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Geubbels E, Amri S, Levira F, Schellenberg J, Masanja H, Nathan R. Health & Demographic Surveillance System Profile: The Ifakara Rural and Urban Health and Demographic Surveillance System (Ifakara HDSS). Int J Epidemiol. 2015;44(3):848–61.

    Article  PubMed  Google Scholar 

  53. Ghosh S, Barik A, Majumder S, Gorain A, Mukherjee S, Mazumdar S, Chatterjee K, Bhaumik SK, Bandyopadhyay SK, Satpathi B, et al. Health & Demographic Surveillance System Profile: The Birbhum population project (Birbhum HDSS). Int J Epidemiol. 2015;44(1):98–107.

    Article  PubMed  Google Scholar 

  54. Gorain A, Barik A, Chowdhury A, Rai RK. Preference in place of delivery among rural Indian women. Plos One. 2017;12(12):e0190117.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  55. Gyapong M, Sarpong D, Awini E, Manyeh AK, Tei D, Odonkor G, Agyepong IA, Mattah P, Wontuo P, Attaa-Pomaa M, et al. Profile: the Dodowa HDSS. Int J Epidemiol. 2013;42(6):1686–96.

    Article  PubMed  Google Scholar 

  56. Hazard RH, Alam N, Chowdhury HR, Adair T, Alam S, Streatfield PK, Riley ID, Lopez AD. Comparing tariff and medical assistant assigned causes of death from verbal autopsy interviews in Matlab, Bangladesh: implications for a health and demographic surveillance system. Popul Health Metr. 2018;16(1):10.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Helleringer S, Pison G, Masquelier B, Kanté AM, Douillot L, Ndiaye CT, Duthé G, Sokhna C, Delaunay V. Improving survey data on pregnancy-related deaths in low-and middle-income countries: a validation study in Senegal. Trop Med Int Health. 2015;20(11):1415–23.

    Article  PubMed  Google Scholar 

  58. Herbst K, Juvekar S, Bhattacharjee T, Bangha M, Patharia N, Tei T, Gilbert B, Sankoh O. The INDEPTH Data Repository: An International Resource for Longitudinal Population and Health Data From Health and Demographic Surveillance Systems. J Empir Res Hum Res Ethics. 2015;10(3):324–33.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Jahn A, Floyd S, McGrath N, Crampin AC, Kachiwanda L, Mwinuka V, Zaba B, Fine PE, Glynn JR. Child mortality in rural Malawi: HIV closes the survival gap between the socio-economic strata. Plos One. 2010;5(6):e11320.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  60. Jasseh M, Gomez P, Greenwood BM, Howie SR, Scott S, Snell PC, Bojang K, Cham M, Corrah T, D'Alessandro U. Health & Demographic Surveillance System Profile: Farafenni Health and Demographic Surveillance System in The Gambia. Int J Epidemiol. 2015;44(3):837–47.

    Article  PubMed  Google Scholar 

  61. Kabudula CW, Houle B, Collinson MA, Kahn K, Gómez-Olivé FX, Tollman S, Clark SJ. Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001-13: a population surveillance analysis. Lancet Glob Health. 2017;5(9):e924–35.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Kadobera D, Waiswa P, Peterson S, Blencowe H, Lawn J, Kerber K, Tumwesigye NM. Comparing performance of methods used to identify pregnant women, pregnancy outcomes, and child mortality in the Iganga-Mayuge Health and Demographic Surveillance Site, Uganda. Glob Health Action. 2017;10(1):1356641.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Kahn K, Collinson MA, Gómez-Olivé FX, Mokoena O, Twine R, Mee P, Afolabi SA, Clark BD, Kabudula CW, Khosa A, et al. Profile: Agincourt health and socio-demographic surveillance system. Int J Epidemiol. 2012;41(4):988–1001.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Kaneko S, K'Opiyo J, Kiche I, Wanyua S, Goto K, Tanaka J, Changoma M, Ndemwa M, Komazawa O, Karama M, et al. Health and Demographic Surveillance System in the Western and coastal areas of Kenya: an infrastructure for epidemiologic studies in Africa. J Epidemiol. 2012;22(3):276–85.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Kant S, Misra P, Gupta S, Goswami K, Krishnan A, Nongkynrih B, Rai SK, Srivastava R, Pandav CS. The Ballabgarh Health and Demographic Surveillance System (CRHSP-AIIMS). Int J Epidemiol. 2013;42(3):758–68.

    Article  PubMed  Google Scholar 

  66. Kishamawe C, Isingo R, Mtenga B, Zaba B, Todd J, Clark B, Changalucha J, Urassa M. Health & Demographic Surveillance System Profile: The Magu Health and Demographic Surveillance System (Magu HDSS). Int J Epidemiol. 2015;44(6):1851–61.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Koné S, Baikoro N, N'Guessan Y, Jaeger FN, Silué KD, Fürst T, Hürlimann E, Ouattara M, Séka MC, N'Guessan NA, et al. Health & Demographic Surveillance System Profile: The Taabo Health and Demographic Surveillance System, Côte d’Ivoire. Int J Epidemiol. 2015;44(1):87–97.

    Article  PubMed  Google Scholar 

  68. Koné S, Hürlimann E, Baikoro N, Dao D, Bonfoh B, N'Goran EK, Utzinger J, Jaeger FN. Pregnancy-related morbidity and risk factors for fatal foetal outcomes in the Taabo health and demographic surveillance system, Côte d’Ivoire. BMC Pregnancy Childbirth. 2018;18(1):216.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Kouanda S, Bado A, Yaméogo M, Nitièma J, Yaméogo G, Bocoum F, Millogo T, Ridde V, Haddad S, Sondo B. The Kaya HDSS, Burkina Faso: a platform for epidemiological studies and health programme evaluation. Int J Epidemiol. 2013;42(3):741–9.

    Article  PubMed  Google Scholar 

  70. Malaviya P, Picado A, Hasker E, Ostyn B, Kansal S, Singh RP, Shankar R, Boelaert M, Sundar S. Health & Demographic Surveillance System profile: the Muzaffarpur-TMRC Health and Demographic Surveillance System. Int J Epidemiol. 2014;43(5):1450–7.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Manyeh AK, Amu A, Akpakli DE, Williams J, Gyapong M. Socioeconomic and demographic factors associated with caesarean section delivery in Southern Ghana: evidence from INDEPTH Network member site. BMC Pregnancy Childbirth. 2018;18(1):405.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Marbán-Castro E, Sacoor C, Nhacolo A, Augusto O, Jamisse E, López-Varela E, Casellas A, Aponte JJ, Bassat Q, Sigauque B, et al. BCG vaccination in southern rural Mozambique: an overview of coverage and its determinants based on data from the demographic and health surveillance system in the district of Manhiça. BMC Pediatr. 2018;18(1):56.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Musa A, Assefa N, Weldegebreal F, Mitiku H, Teklemariam Z. Factor associated with experience of modern contraceptive use before pregnancy among women who gave birth in Kersa HDSS, Ethiopia. BMC Public Health. 2016;16:614.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Odhiambo FO, Laserson KF, Sewe M, Hamel MJ, Feikin DR, Adazu K, Ogwang S, Obor D, Amek N, Bayoh N, et al. Profile: the KEMRI/CDC Health and Demographic Surveillance System--Western Kenya. Int J Epidemiol. 2012;41(4):977–87.

    Article  PubMed  Google Scholar 

  75. Partap U, Young EH, Allotey P, Sandhu MS, Reidpath DD. Characterisation and correlates of stunting among Malaysian children and adolescents aged 6-19 years. Glob Health Epidemiol Genom. 2019;4:e2.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Partap U, Young EH, Allotey P, Soyiri IN, Jahan N, Komahan K, Devarajan N, Sandhu MS, Reidpath DD. HDSS Profile: The South East Asia Community Observatory Health and Demographic Surveillance System (SEACO HDSS). Int J Epidemiol. 2017;46(5):1370–1371g.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Pison G, Beck B, Ndiaye O, Diouf PN, Senghor P, Duthé G, Fleury L, Sokhna C, Delaunay V. HDSS Profile: Mlomp Health and Demographic Surveillance System (Mlomp HDSS), Senegal. Int J Epidemiol. 2018;47(4):1025–33.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Pison G, Douillot L, Kante AM, Ndiaye O, Diouf PN, Senghor P, Sokhna C, Delaunay V. Health & demographic surveillance system profile: Bandafassi Health and Demographic Surveillance System (Bandafassi HDSS), Senegal. Int J Epidemiol. 2014;43(3):739–48.

    Article  PubMed  Google Scholar 

  79. Price J, Willcox M, Kabudula CW, Herbst K, Kahn K, Harnden A. Home deaths of children under 5 years in rural South Africa: a population-based longitudinal study. Trop Med Int Health. 2019;24(7):862–78.

    PubMed  Google Scholar 

  80. Rosário EVN, Costa D, Francisco D, Brito M. HDSS Profile: The Dande Health and Demographic Surveillance System (Dande HDSS, Angola). Int J Epidemiol. 2017;46(4):1094–1094g.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Rossier C, Muindi K, Soura A, Mberu B, Lankoande B, Kabiru C, Millogo R. Maternal health care utilization in Nairobi and Ouagadougou: evidence from HDSS. Glob Health Action. 2014;7:24351.

    Article  PubMed  Google Scholar 

  82. Rossier C, Soura A, Baya B, Compaoré G, Dabiré B, Dos Santos S, Duthé G, Gnoumou B, Kobiané JF, Kouanda S, et al. Profile: the Ouagadougou Health and Demographic Surveillance System. Int J Epidemiol. 2012;41(3):658–66.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Sacoor C, Nhacolo A, Nhalungo D, Aponte JJ, Bassat Q, Augusto O, Mandomando I, Sacarlal J, Lauchande N, Sigaúque B, et al. Profile: Manhiça Health Research Centre (Manhiça HDSS). Int J Epidemiol. 2013;42(5):1309–18.

    Article  PubMed  Google Scholar 

  84. Sacoor C, Payne B, Augusto O, Vilanculo F, Nhacolo A, Vidler M, Makanga PT, Munguambe K, Lee T, Macete E, et al. Health and socio-demographic profile of women of reproductive age in rural communities of southern Mozambique. Plos One. 2018;13(2):e0184249.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  85. Salzberg NT, Sivalogan K, Bassat Q, Taylor AW, Adedini S, El Arifeen S, Assefa N, Blau DM, Chawana R, Cain CJ, et al. Mortality Surveillance Methods to Identify and Characterize Deaths in Child Health and Mortality Prevention Surveillance Network Sites. Clin Infect Dis. 2019;69(Suppl 4):S262–s273.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Sankoh O, Byass P. Cause-specific mortality at INDEPTH Health and Demographic Surveillance System Sites in Africa and Asia: concluding synthesis. Glob Health Action. 2014;7:25590.

    Article  PubMed  Google Scholar 

  87. Sankoh O, Sharrow D, Herbst K, Whiteson Kabudula C, Alam N, Kant S, Ravn H, Bhuiya A, Thi Vui L, Darikwa T, et al. The INDEPTH standard population for low- and middle-income countries, 2013. Glob Health Action. 2014;7:23286.

    Article  PubMed  Google Scholar 

  88. Scott JA, Bauni E, Moisi JC, Ojal J, Gatakaa H, Nyundo C, Molyneux CS, Kombe F, Tsofa B, Marsh K, et al. Profile: The Kilifi Health and Demographic Surveillance System (KHDSS). Int J Epidemiol. 2012;41(3):650–7.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Selemani M, Mwanyangala MA, Mrema S, Shamte A, Kajungu D, Mkopi A, Mahande MJ, Nathan R. The effect of mother’s age and other related factors on neonatal survival associated with first and second birth in rural, Tanzania: evidence from Ifakara health and demographic surveillance system in rural Tanzania. BMC Pregnancy Childbirth. 2014;14:240.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Sié A, Louis VR, Gbangou A, Müller O, Niamba L, Stieglbauer G, Yé M, Kouyaté B, Sauerborn R, Becher H. The Health and Demographic Surveillance System (HDSS) in Nouna, Burkina Faso, 1993-2007. Glob Health Action. 2010;3(1).

  91. Sifuna P, Otieno L, Ogwang S, Ogutu B, Andagalu B, Owuoth J, Singoei V, Cowden J, Otieno W. Cause-specific mortality in the Kombewa health and demographic surveillance systems site, rural Western Kenya from 2011-2015. Glob Health Action. 2018;11(1):1442959.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Sifuna P, Oyugi M, Ogutu B, Andagalu B, Otieno A, Owira V, Otsyula N, Oyieko J, Cowden J, Otieno L, et al. Health & demographic surveillance system profile: The Kombewa health and demographic surveillance system (Kombewa HDSS). Int J Epidemiol. 2014;43(4):1097–104.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Streatfield PK, Alam N, Compaoré Y, Rossier C, Soura AB, Bonfoh B, Jaeger F, Ngoran EK, Utzinger J, Gomez P, et al. Pregnancy-related mortality in Africa and Asia: evidence from INDEPTH Health and Demographic Surveillance System sites. Glob Health Action. 2014;7:25368.

    Article  PubMed  Google Scholar 

  94. Streatfield PK, Khan WA, Bhuiya A, Alam N, Sié A, Soura AB, Bonfoh B, Ngoran EK, Weldearegawi B, Jasseh M, et al. Cause-specific mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites. Glob Health Action. 2014;7:25362.

    Article  PubMed  Google Scholar 

  95. Streatfield PK, Khan WA, Bhuiya A, Hanifi SM, Alam N, Ouattara M, Sanou A, Sié A, Lankoandé B, Soura AB, et al. Cause-specific childhood mortality in Africa and Asia: evidence from INDEPTH health and demographic surveillance system sites. Glob Health Action. 2014;7:25363.

    Article  PubMed  Google Scholar 

  96. Tesfaye G, Loxton D, Chojenta C, Assefa N, Smith R. Magnitude, trends and causes of maternal mortality among reproductive aged women in Kersa health and demographic surveillance system, eastern Ethiopia. BMC Womens Health. 2018;18(1):198.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Thysen SM, Fernandes M, Benn CS, Aaby P, Fisker AB. Cohort profile : Bandim Health Project's (BHP) rural Health and Demographic Surveillance System (HDSS)-a nationally representative HDSS in Guinea-Bissau. BMJ Open. 2019;9(6):e028775.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Tinto H, Sevene E, Dellicour S, Calip GS, d'Alessandro U, Macete E, Nakanabo-Diallo S, Kazienga A, Valea I, Sorgho H, et al. Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique. Reprod Health. 2015;12:112.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  99. Tran TK, Nguyen CT, Nguyen HD, Eriksson B, Bondjers G, Gottvall K, Ascher H, Petzold M. Urban - rural disparities in antenatal care utilization: a study of two cohorts of pregnant women in Vietnam. BMC Health Serv Res. 2011;11:120.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Waiswa P, Akuze J, Moyer C, Kwesiga D, Arthur S, Sankoh O, Welaga P, Bangha M, Eminas J, Muuo S, et al. Status of birth and pregnancy outcome capture in Health Demographic Surveillance Sites in 13 countries. Int J Public Health. 2019;64(6):909–20.

    Article  PubMed  Google Scholar 

  101. Wanyua S, Ndemwa M, Goto K, Tanaka J, K'Opiyo J, Okumu S, Diela P, Kaneko S, Karama M, Ichinose Y, et al. Profile: the Mbita health and demographic surveillance system. Int J Epidemiol. 2013;42(6):1678–85.

    Article  PubMed  Google Scholar 

  102. The Global Network for Women’s and Children’s Health Research. In. s.l.: Foundation for the National Institutes of Health; 2019. https://www.nichd.nih.gov/research/supported/globalnetwork. Accessed 20 May 2020.

  103. RTI: Research Triangle Institute. https://www.rti.org/. Accessed 20 june 2020.

  104. Goudar S, Goco N, Somannavar M, Vernekar S, Mallapur A, Moore J, Wallace D, Sloan N, Archana P, Hibberd P, et al. Institutional deliveries and perinatal and neonatal mortality in southern and central India. (Special Issue: Research reports from the NICHD Global Network for Women's and Children's Health Research Maternal and Newborn Health Registry.). Reprod Health. 2015;12(Suppl 2):S13 33 ref 2015.

    Google Scholar 

  105. Althabe F, Moore JL, Gibbons L, Berrueta M, Goudar SS, Chomba E, Derman RJ, Patel A, Saleem S, Pasha O, et al. Adverse maternal and perinatal outcomes in adolescent pregnancies: The Global Network's Maternal Newborn Health Registry study. Reprod Health. 2015;12(Suppl 2):S8.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Belizán JM, McClure EM, Goudar SS, Pasha O, Esamai F, Patel A, Chomba E, Garces A, Wright LL, Koso-Thomas M, et al. Neonatal death in low- to middle-income countries: a global network study. Am J Perinatol. 2012;29(8):649–56.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Bellad MB, Vidler M, Honnungar NV, Mallapur A, Ramadurg U, Charanthimath U, Katageri G, Bannale S, Kavi A, Karadiguddi C, et al. Maternal and Newborn Health in Karnataka State, India: The Community Level Interventions for Pre-Eclampsia (CLIP) Trial's Baseline Study Results. Plos One. 2017;12(1):e0166623.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  108. Bose CL, Bauserman M, Goldenberg RL, Goudar SS, McClure EM, Pasha O, Carlo WA, Garces A, Moore JL, Miodovnik M, et al. The Global Network Maternal Newborn Health Registry: a multi-national, community-based registry of pregnancy outcomes. Reprod Health. 2015;12(Suppl 2):S1.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Bucher S, Marete I, Tenge C, Liechty EA, Esamai F, Patel A, Goudar SS, Kodkany B, Garces A, Chomba E, et al. A prospective observational description of frequency and timing of antenatal care attendance and coverage of selected interventions from sites in Argentina, Guatemala, India, Kenya, Pakistan and Zambia. Reprod Health. 2015;12(Suppl 2):S12.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Dhaded SM, Somannavar MS, Vernekar SS, Goudar SS, Mwenche M, Derman R, Moore JL, Patel A, Pasha O, Esamai F, et al. Neonatal mortality and coverage of essential newborn interventions 2010 - 2013: a prospective, population-based study from low-middle income countries. Reprod Health. 2015;12(Suppl 2):S6.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Duffy CR, Moore JL, Saleem S, Tshefu A, Bose CL, Chomba E, Carlo WA, Garces AL, Krebs NF, Hambidge KM, et al. Malpresentation in low- and middle-income countries: Associations with perinatal and maternal outcomes in the Global Network. Acta Obstet Gynecol Scand. 2019;98(3):300–8.

    Article  PubMed  Google Scholar 

  112. Gisore P, Shipala E, Otieno K, Rono B, Marete I, Tenge C, Mabeya H, Bucher S, Moore J, Liechty E, et al. Community based weighing of newborns and use of mobile phones by village elders in rural settings in Kenya: a decentralised approach to health care provision. BMC Pregnancy Childbirth. 2012;12:15.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Goldenberg RL, McClure EM, Bose CL, Jobe AH, Belizán JM. Research results from a registry supporting efforts to improve maternal and child health in low and middle income countries. Reprod Health. 2015;12:54.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Goldenberg RL, Thorsten VR, Althabe F, Saleem S, Garces A, Carlo WA, Pasha O, Chomba E, Goudar S, Esamai F, et al. The global network antenatal corticosteroids trial: impact on stillbirth. Reprod Health. 2016;13(1):68.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  115. Goudar SS, Goco N, Somannavar MS, Vernekar SS, Mallapur AA, Moore JL, Wallace DD, Sloan NL, Patel A, Hibberd PL, et al. Institutional deliveries and perinatal and neonatal mortality in Southern and Central India. Reprod Health. 2015;12(Suppl 2):S13.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Goudar SS, Stolka KB, Koso-Thomas M, Honnungar NV, Mastiholi SC, Ramadurg UY, Dhaded SM, Pasha O, Patel A, Esamai F, et al. Data quality monitoring and performance metrics of a prospective, population-based observational study of maternal and newborn health in low resource settings. Reprod Health. 2015;12(Suppl 2):S2.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Harrison MS, Ali S, Pasha O, Saleem S, Althabe F, Berrueta M, Mazzoni A, Chomba E, Carlo WA, Garces A, et al. A prospective population-based study of maternal, fetal, and neonatal outcomes in the setting of prolonged labor, obstructed labor and failure to progress in low- and middle-income countries. Reprod Health. 2015;12(Suppl 2):S9.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Kodkany BS, Derman RJ, Honnungar NV, Tyagi NK, Goudar SS, Mastiholi SC, Moore JL, McClure EM, Sloan N, Goldenberg RL. Establishment of a Maternal Newborn Health Registry in the Belgaum District of Karnataka, India. Reprod Health. 2015;12(Suppl 2):S3.

    Article  PubMed  PubMed Central  Google Scholar 

  119. McClure EM, Garces A, Saleem S, Moore JL, Bose CL, Esamai F, Goudar SS, Chomba E, Mwenechanya M, Pasha O, et al. Global Network for Women's and Children’s Health Research: probable causes of stillbirth in low- and middle-income countries using a prospectively defined classification system. BJOG. 2018;125(2):131–8.

    Article  CAS  PubMed  Google Scholar 

  120. McClure EM, Saleem S, Goudar SS, Moore JL, Garces A, Esamai F, Patel A, Chomba E, Althabe F, Pasha O, et al. Stillbirth rates in low-middle income countries 2010 - 2013: a population-based, multi-country study from the Global Network. Reprod Health. 2015;12(Suppl 2):S7.

    Article  PubMed  PubMed Central  Google Scholar 

  121. Pasha O, Goudar SS, Patel A, Garces A, Esamai F, Chomba E, Moore JL, Kodkany BS, Saleem S, Derman RJ, et al. Postpartum contraceptive use and unmet need for family planning in five low-income countries. Reprod Health. 2015;12(Suppl 2):S11.

    Article  PubMed  PubMed Central  Google Scholar 

  122. Pasha O, McClure EM, Saleem S, Tikmani SS, Lokangaka A, Tshefu A, Bose CL, Bauserman M, Mwenechanya M, Chomba E, et al. A prospective cause of death classification system for maternal deaths in low and middle-income countries: results from the Global Network Maternal Newborn Health Registry. BJOG. 2018;125(9):1137–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Pasha O, Saleem S, Ali S, Goudar SS, Garces A, Esamai F, Patel A, Chomba E, Althabe F, Moore JL, et al. Maternal and newborn outcomes in Pakistan compared to other low and middle income countries in the Global Network's Maternal Newborn Health Registry: an active, community-based, pregnancy surveillance mechanism. Reprod Health. 2015;12(Suppl 2):S15.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Patel A, Bucher S, Pusdekar Y, Esamai F, Krebs NF, Goudar SS, Chomba E, Garces A, Pasha O, Saleem S, et al. Rates and determinants of early initiation of breastfeeding and exclusive breast feeding at 42 days postnatal in six low and middle-income countries: A prospective cohort study. Reprod Health. 2015;12(Suppl 2):S10.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Saleem S, Tikmani SS, McClure EM, Moore JL, Azam SI, Dhaded SM, Goudar SS, Garces A, Figueroa L, Marete I, et al. Trends and determinants of stillbirth in developing countries: results from the Global Network's Population-Based Birth Registry. Reprod Health. 2018;15(Suppl 1):100.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Short VL, Geller SE, Moore JL, McClure EM, Goudar SS, Dhaded SM, Kodkany BS, Saleem S, Naqvi F, Pasha O, et al. The Relationship between Body Mass Index in Pregnancy and Adverse Maternal, Perinatal, and Neonatal Outcomes in Rural India and Pakistan. Am J Perinatol. 2018;35(9):844–51.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Tikmani SS, Ali SA, Saleem S, Bann CM, Mwenechanya M, Carlo WA, Figueroa L, Garces AL, Krebs NF, Patel A, et al. Trends of antenatal care during pregnancy in low- and middle-income countries: Findings from the global network maternal and newborn health registry. Semin Perinatol. 2019;43(5):297–307.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Review of DHIS2 implementation experience: findings and lessons learnt. In. Bangkok: Thailand. Ministry of Health. 2016. https://accesstohealthfund.org/. Accesseed 10 May 2020.

  129. Health Management Information Systems (HMIS): Review Survey on Data Availability in Electronic Systems for Maternal and Newborn Health Indicators in 24 USAID Priority Countries. In. Washington, DC: Unites States. Maternal and Child Survival Program. 2016. https://www.mcsprogram.org/. Accessed 25 May 2020.

  130. Standard Operating Procedures (SOP) for Routine Registry Operations- Implementation, Establishment and Maintenance of Mother & Child Health (MCH) Registry: Communication Strategies. In. Ramala: Palestina. National Institute of Public Health. 2017. https://www.pniph.org/. Accessed 20 May 2020.

  131. DHIS2 District Health Information Software 2. https://www.dhis2.org/. Accessed 20 May 2020.

  132. DHIS 2 Implementer guide: Applicable to master version. In. s.l.: DHIS2. 2020. https://docs.dhis2.org/. Accessed 20 May 2020.

  133. Begum T, Khan SM, Ferdous J, Parvez MM, Rahman A, Kumkum FA, Anwa I. Using DHIS 2 Software to Collect Health Data in Bangladesh. In. Chapel Hill: MEASURE Evaluation; 2019.

    Google Scholar 

  134. Rawlins B: Measurement Matters! Improving Routine RMNCAH Data for Better Outcomes. In. Washington, DC: Unites States. USAIDS. Maternal and Child Survival Program. 2019. https://www.mcsprogram.org/. Accessed 23 June 2020.

  135. Singh GP: Improving Data for Decision-making: Leveraging Data Quality Audits in Haryana, India. In. DelhI: United States. Health Finance and Governance Project. 2014. https://www.hfgproject.org/. Accessed 1 July 2020.

  136. Unicef: Health System Strengthening: Transforming the health information system in Bangladesh: Case Study Bangladesh. In. s.l.: UNICEF Regional Office for South Asia. 2019. https://www.unicef.org/. Accessed 2 July 2020.

  137. Bergum B-I, Kusumasindra F, Øren M, Falch V, Sahraoui T: Analyzing DHIS2 as an information infrastructure. Information infrastructure. 2015. https://www.uio.no/. Accessed 7 May 2020.

  138. Valbø B: Introducing a complex health information system in a developing country: Case: The Gambia. Oslo: Unievrsity of Oslo. 2010. https://www.duo.uio.no/. Accessed 5 May 2020.

  139. Manya A, Nielsen P. Reporting practices and data quality in health information systems in developing countries: an exploratory case study in Kenya. J Health Inform Dev Countries. 2016;10(1):114–26 28 ref 2016.

    Google Scholar 

  140. Barron P, Peter J, LeFevre AE, Sebidi J, Bekker M, Allen R, Parsons AN, Benjamin P, Pillay Y. Mobile health messaging service and helpdesk for South African mothers (MomConnect): history, successes and challenges. BMJ Glob Health. 2018;3(Suppl 2):e000559.

    Article  PubMed  PubMed Central  Google Scholar 

  141. Barron P, Pillay Y, Fernandes A, Sebidi J, Allen R. The MomConnect mHealth initiative in South Africa: Early impact on the supply side of MCH services. J Public Health Policy. 2016;37(Suppl 2):201–12.

    Article  PubMed  Google Scholar 

  142. Begum T, Khan SM, Adamou B, Ferdous J, Parvez MM, Islam MS, Kumkum FA, Rahman A, Anwar I. Perceptions and experiences with district health information system software to collect and utilize health data in Bangladesh: a qualitative exploratory study. BMC Health Serv Res. 2020;20(1):465.

    Article  PubMed  PubMed Central  Google Scholar 

  143. Beguy D, Elung'ata P, Mberu B, Oduor C, Wamukoya M, Nganyi B, Ezeh A. Health & Demographic Surveillance System Profile: The Nairobi Urban Health and Demographic Surveillance System (NUHDSS). Int J Epidemiol. 2015;44(2):462–71.

    Article  PubMed  Google Scholar 

  144. Faujdar DS, Sahay S, Singh T, Jindal H, Kumar R. Public health information systems for primary health care in India: A situational analysis study. J Fam Med Prim Care. 2019;8(11):3640–6.

    Article  Google Scholar 

  145. Hassan S, Vikanes A, Laine K, Zimmo K, Zimmo M, Bjertness E, Fosse E. Building a research registry for studying birth complications and outcomes in six Palestinian governmental hospitals. BMC Pregnancy Childbirth. 2017;17(1):112.

    Article  PubMed  PubMed Central  Google Scholar 

  146. Heekes A, Tiffin N, Dane P, Mutemaringa T, Smith M, Zinyakatira N, Barron P, Seebregts C, Boulle A. Self-enrolment antenatal health promotion data as an adjunct to maternal clinical information systems in the Western Cape Province of South Africa. BMJ Glob Health. 2018;3(Suppl 2):e000565.

    Article  PubMed  PubMed Central  Google Scholar 

  147. LeFevre AE, Dane P, Copley CJ, Pienaar C, Parsons AN, Engelhard M, Woods D, Bekker M, Benjamin P, Pillay Y, et al. Unpacking the performance of a mobile health information messaging program for mothers (MomConnect) in South Africa: evidence on program reach and messaging exposure. BMJ Glob Health. 2018;3(Suppl 2):e000583.

    Article  PubMed  PubMed Central  Google Scholar 

  148. Seebregts C, Dane P, Parsons AN, Fogwill T, Rogers D, Bekker M, Shaw V, Barron P. Designing for scale: optimising the health information system architecture for mobile maternal health messaging in South Africa (MomConnect). BMJ Glob Health. 2018;3(Suppl 2):e000563.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Xiong K, Kamunyori J, Sebidi J. The MomConnect helpdesk: how an interactive mobile messaging programme is used by mothers in South Africa. BMJ Glob Health. 2018;3(Suppl 2):e000578.

    Article  PubMed  PubMed Central  Google Scholar 

  150. Venkateswaran M, Mørkrid K, Abu Khader K, Awwad T, Friberg IK, Ghanem B, Hijaz T, Frøen JF. Comparing individual-level clinical data from antenatal records with routine health information systems indicators for antenatal care in the West Bank: A cross-sectional study. Plos One. 2018;13(11):e0207813.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  151. Seebregts C, Barron P, Tanna G, Benjamin P, Fogwill T. MomConnect: an exemplar implementation of the Health Normative Standards Framework in South Africa. South Afr Health Rev. 2016;2016:125–35 36 ref 2016.

    Google Scholar 

  152. OpenMRS: Open Medical Record System. 2020. https://openmrs.org/. Accessed 4 May 2020.

  153. Bashiri A, Ghazisaeedi M. Open MRS softwares: effective approaches in management of patients’ health information. Int J Commun Med Publ Health. 2017;4(11):4.

    Article  Google Scholar 

  154. Downey M, Mamlin B: OpenMRS Wiki. In. s.l.: OpenMRS. 2017. https://wiki.openmrs.org/. Accessed 4 may 2020.

  155. Allen C, Jazayeri D, Miranda J, Biondich PG, Mamlin BW, Wolfe BA, Seebregts C, Lesh N, Tierney WM, Fraser HS. Experience in implementing the OpenMRS medical record system to support HIV treatment in Rwanda. Stud Health Technol Inform. 2007;129(Pt 1):382–6.

    PubMed  Google Scholar 

  156. Mamlin BW, Biondich PG, Wolfe BA, Fraser H, Jazayeri D, Allen C, Miranda J, Tierney WM. Cooking up an open source EMR for developing countries: OpenMRS - a recipe for successful collaboration. AMIA Annu Symp Proc. 2006;2006:529–33.

    PubMed Central  Google Scholar 

  157. Manders EJ, José E, Solis M, Burlison J, Nhampossa JL, Moon T. Implementing OpenMRS for patient monitoring in an HIV/AIDS care and treatment program in rural Mozambique. Stud Health Technol Inform. 2010;160(Pt 1):411–5.

    PubMed  Google Scholar 

  158. Satti H, Motsamai S, Chetane P, Marumo L, Barry DJ, Riley J, McLaughlin MM, Seung KJ, Mukherjee JS. Comprehensive approach to improving maternal health and achieving MDG 5: report from the mountains of Lesotho. Plos One. 2012;7(8):e42700.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  159. Thompson A, Castle E, Lubeck P, Makarfi PS. Experience implementing OpenMRS to support maternal and reproductive health in Northern Nigeria. Stud Health Technol Inform. 2010;160(Pt 1):332–6.

    PubMed  Google Scholar 

  160. Tierney WM, Achieng M, Baker E, Bell A, Biondich P, Braitstein P, Kayiwa D, Kimaiyo S, Mamlin B, McKown B, et al. Experience implementing electronic health records in three East African countries. Stud Health Technol Inform. 2010;160(Pt 1):371–5.

    PubMed  Google Scholar 

  161. Sistema Informático Perinatal. 2020. http://www.clap.ops-oms.org/. Accessed 15 May 2020.

  162. Fescina R: History of the Perinatal Information System. Making Pregnancy Safer. 2010. https://www.paho.org/. Accessed 15 May 2020.

  163. Mainero L, Martínez G, Rubino M, De Mucio B, Díaz Rosello JL, Fescina R: Sistema informático perinatal (SIP): manual de uso del programa para el análisis y aprovechamiento de la información. Sci Publ; 1565-02 2010. Accessed 24 May 2020.

  164. Bradley H, Tapia V, Kamb ML, Newman LM, Garcia PJ, Serruya SJ, Fort AL, Broutet N, Nelson R, Kirkcaldy RD, et al. Can the Perinatal Information System in Peru be used to measure the proportion of adverse birth outcomes attributable to maternal syphilis infection? Rev Panam Salud Publica. 2014;36(2):73–9.

    PubMed  Google Scholar 

  165. Karolinski A, Mercer R, Bolzán A, Salgado P, Ocampo C, Nieto R, Birmingham M, Martínez G, Mainero L. Serruya S et al: [Foundations for the development and implementation of a women's and perinatal health information model for management in Latin AmericaFundamentos do desenvolvimento e implementação de um modelo de informação em saúde da materna e perinatal orientado à gestão na América Latina]. Rev Panam Salud Publica. 2018;42:e148.

    PubMed  PubMed Central  Google Scholar 

  166. Serruya SJ, Duran P, Martinez G, Romero M, Caffe S, Alonso M, Silveira MF. Maternal and congenital syphilis in selected Latin America and Caribbean countries: a multi-country analysis using data from the Perinatal Information System. Sex Health. 2015;12(2):164–9.

    Article  PubMed  Google Scholar 

  167. Levine R, Corbacio A, Konopka S, Saya U, Gilmartin C, Paradis J, Haas S. mHealth Compendium. 5. Arlington: United States Agency for International Development; 2015. http://www.africanstrategies4health.org/. Accessed 15 May 2020

    Google Scholar 

  168. Open Smart Register Platform (OpenSRP): Delivering a longitudinal patient record and decision support system for frontline health workers. 2020. https://www.who.int/reproductivehealth/topics/mhealth/openspr/en/. Accessed 27 May 2020.

    Google Scholar 

  169. THRIVE Indonesia: An Integrated, Mobile Health Information System Enhances Maternal And Neonatal Health Outcomes. 2020. https://smartcitiescouncil.com/resources/thrive-indonesia-integrated-mobile-health-information-system-enhances-maternal-and-neonatal-health. Accessed 20 May 2020.

  170. OpenSRP: Open Smart Register Platform. 2020. http://smartregister.org/index.html. Accessed 20 May 2020.

  171. Kevin K, Inraini F, Ahmad Rafi J, Resty Asmauryanah A, Yusran L, Muhammad Abdi H, Benyamin H, Anuraj S. Midwife service coverage, quality of work, and client health improved after deployment of an OpenSRP-driven client management application in Indonesia. In: 5th International Conference on Health Sciences (ICHS 2018): 2019/11 2019: Atlantis Press; 2019:155–62. https://download.atlantis-press.com/proceedings/ichs-18/125921329. Accessed 20 May 2020.

  172. Haddad SM, Souza RT, Cecatti JG. Mobile technology in health (mHealth) and antenatal care-Searching for apps and available solutions: A systematic review. Int J Med Inform. 2019;127:1–8.

    Article  PubMed  Google Scholar 

  173. Kalk E, Mehta U, Slogrove A, Jacob N, Myer L, Davies MA, Boulle A. Pregnancy exposure registry/birth defects surveillance programme in the Western Cape, South Africa: A model for low- and middle-income countries. Drug Saf. 2018;41(11):1212–3.

    Google Scholar 

  174. Mehta U, Heekes A, Kalk E, Boulle A. Assessing the value of Western Cape Provincial Government health administrative data and electronic pharmacy records in ascertaining medicine use during pregnancy. S Afr Med J. 2018;108(5):439–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  175. Mehta UC, van Schalkwyk C, Naidoo P, Ramkissoon A, Mhlongo O, Maharaj NR, Naidoo N, Fieggen K, Urban MF, Krog S, et al. Birth outcomes following antiretroviral exposure during pregnancy: Initial results from a pregnancy exposure registry in South Africa. South Afr J HIV Med. 2019;20(1):971.

    Article  PubMed  PubMed Central  Google Scholar 

  176. Dheda M: Pregnancy Registers. In. Midrand: South Africa. National Department of Health. 2018. https://www.sahivsoc2018.co.za/. Accessed 20 May 2020.

  177. Epidemiology for Data Users (EDU) Trainer‘s Manual. In. Lusaka: Zambia. Ministry of Health. 2011. https://www.nastad.org/. Accessed 17 June 2020.

  178. SmartCare. 2020. https://helpdesk.moh.gov.zm/. Accessed 15 june 2020.

  179. Gumede-Moyo S, Todd J, Bond V, Mee P, Filteau S. A qualitative inquiry into implementing an electronic health record system (SmartCare) for prevention of mother-to-child transmission data in Zambia: a retrospective study. BMJ Open. 2019;9(9):e030428.

    Article  PubMed  PubMed Central  Google Scholar 

  180. Mweebo K. Security of electronic health records in a resource limited setting: The case of smart-care electronic health record in Zambia. SRI Security Research Institute, Edith Cowan University. In: 3rd Australian eHealth Informatics and Security Conference. Perth, Australia; 2014. https://doi.org/10.4225/75/5798297631b47.

  181. Footman K, Chersich M, Blaauw D, Campbell OM, Dhana A, Kavanagh J, Dumbaugh M, Thwala S, Bijlmakers L, Vargas E, et al. A systematic mapping of funders of maternal health intervention research 2000-2012. Global Health. 2014;10:72.

    Article  PubMed  PubMed Central  Google Scholar 

  182. Fairlie L, Mehta UC: National pregnancy exposure registry for South Africa In. Edited by Buekens PM; 2020.

  183. Baiden R, Oduro A, Halidou T, Gyapong M, Sie A, Macete E, Abdulla S, Owusu-Agyei S, Mulokozi A, Adjei A, et al. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania. Malar J. 2015;14:160.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  184. Bonhoeffer J, Kochhar S, Hirschfeld S, Heath PT, Jones CE, Bauwens J, Honrado Á, Heininger U, Muñoz FM, Eckert L, et al. Global alignment of immunization safety assessment in pregnancy - The GAIA project. Vaccine. 2016;34(49):5993–7.

    Article  PubMed  Google Scholar 

  185. Frøen JF, Myhre SL, Frost MJ, Chou D, Mehl G, Say L, Cheng S, Fjeldheim I, Friberg IK, French S, et al. eRegistries: Electronic registries for maternal and child health. BMC Pregnancy Childbirth. 2016;16:11.

    Article  PubMed  PubMed Central  Google Scholar 

  186. Crawford M, van Wyk J, Aboud M, Vannappagari V, Romach B, Curtis L, Wynne B, de Ruiter A, Smith K, Payvandi N. Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use. J Acquir Immune Defic Syndr. 2020;83(1):e2–5.

    Article  PubMed  Google Scholar 

  187. IMPAACT Studies. 2020. https://impaactnetwork.org/studies/index.asp. Accessed 26 May 2020.

  188. Tricco AC, Lillie E, Zarin W, O'Brien K, Colquhoun H, Kastner M, Levac D, Ng C, Sharpe JP, Wilson K, et al. A scoping review on the conduct and reporting of scoping reviews. BMC Med Res Methodol. 2016;16:15.

    Article  PubMed  PubMed Central  Google Scholar 

  189. Sobanjo-Ter Meulen A, Liljestrand J, Lawn JE, Hombach J, Smith J, Dickson KE, Munoz FM, Omer SB, Williams BA, Klugman KP. Preparing to introduce new maternal immunizations in low- and lower-middle-income countries: A report from the Bill & Melinda Gates Foundation convening “Allies in Maternal and Newborn Care”; May 3-4, 2018. Vaccine. 2020;38(28):4355–61.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Andrea Meyer and Sarah Matthews for English editing. We could not have done this study without the collaboration and dedication of the Scoping Review Collaboration Group (author names and affiliation): Judith Absalon, MD, MPH (Pfizer, Inc); Steve Anderson, PhD, MPP (US Food & Drug Administration); Fernando Althabe, MD (World Health Organization); Shabir Madhi, MBBCh, FCPaeds, PhD (University of the Witwatersrand); Elizabeth McClure, PhD (Research Triangle Institute; University of North Carolina at Chapel Hill); Flor M. Munoz, MD, MSc (Baylor College of Medicine); Kissa W. Mwamwitwa, Mpharm (Tanzania Medicines & Medical Devices Authority); Annettee Nakimuli, MD, MMed Obs&gyn, PhD (Kaiser Permanente Washington Health Research Institute); Jennifer Clark Nelson, PhD (Makerere University); Lisa Noguchi, PhD, CNM (Johns Hopkins University/Jhpiego); Lakshmi Panagiotakopoulos, MD, MPH (Centers for Disease Control and Prevention); Esperanca Sevene, MD, MSc, PhD (Eduardo Mondlane University); Patrick Zuber, MD (World Health Organization); Maria Belizan, MSC (Institute for Clinical Effectiveness and Health Policy); Eduardo Bergel, PhD (Institute for Clinical Effectiveness and Health Policy); Alvaro Ciganda, BSCS (Institute for Clinical Effectiveness and Health Policy); Daniel Comande, BSc (Institute for Clinical Effectiveness and Health Policy); and Veronica Pingray, MPH (Institute for Clinical Effectiveness and Health Policy).

Funding

This work was funded by Bill & Melinda Gates Foundation (BMGF) (INV008443). The funding agency had no role in the final decision to submit the manuscript. Ajoke Sobanjo-ter Meulen (author affiliation: Bill & Melinda Gates Foundation) provided feedback on Conceptualization, Methodology, Writing, Review and Editing.

Author information

Authors and Affiliations

  1. Instituto de Efectividad Clínica y Sanitaria (IECS), Dr. Emilio Ravignani 2024 (C1014CPV), Buenos Aires, Argentina

    Mabel Berrueta, Agustin Ciapponi, Ariel Bardach, Federico Rodriguez Cairoli & Fabricio J. Castellano

  2. Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, 70112, USA

    Xu Xiong & Pierre Buekens

  3. University of Washington, Seattle, WA, 98195-7631, USA

    Andy Stergachis & Sabra Zaraa

  4. Bill & Melinda Gates Foundation, Seattle, WA, USA

    Ajoke Sobanjo-ter Meulen

Authors
  1. Mabel Berrueta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Agustin Ciapponi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ariel Bardach
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Federico Rodriguez Cairoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fabricio J. Castellano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xu Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andy Stergachis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sabra Zaraa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Ajoke Sobanjo-ter Meulen
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Pierre Buekens
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

Scoping Review Collaboration Group

  • Judith Absalon
  • , Steve Anderson
  • , Fernando Althabe
  • , Shabir Madhi
  • , Elizabeth McClure
  • , Flor M. Munoz
  • , Kissa W. Mwamwitwa
  • , Annettee Nakimuli
  • , Jennifer Clark Nelson
  • , Lisa Noguchi
  • , Lakshmi Panagiotakopoulos
  • , Esperanca Sevene
  • , Patrick Zuber
  • , Maria Belizan
  • , Eduardo Bergel
  • , Alvaro Ciganda
  • , Daniel Comande
  •  & Veronica Pingray

Contributions

MB: Conceptualization, Investigation, Methodology, Project administration, Supervision, Writing, Review and Editing. AC: Methodology, Project administration, Supervision, Writing, Review and Editing. AB: Methodology, Project administration, Supervision, Writing, Review and Editing. FRC: Investigation, Methodology, Writing, Review and Editing. FC: Investigation, Methodology, Writing, Review and Editing. XX: Conceptualization, Methodology, Writing, Review and Editing. AS: Conceptualization, Methodology, Writing, Review and Editing. SZ: Investigation, Methodology, Writing, Review and Editing. ASM: Conceptualization, Methodology, Writing, Review and Editing. PB: Conceptualization, Funding Acquisition, Methodology, Project administration, Supervision, Writing, Review and Editing. Scoping Review Collaboration Group: Methodology, Writing, Review and Editing. All authors have approved the submitted version.

Corresponding author

Correspondence to Mabel Berrueta.

Ethics declarations

Ethics approval and consent to participate

Not applicable since this is a secondary research.

Consent for publication

Not applicable

Competing interests

The authors take sole responsibility for the writing and content of the paper. All authors have nothing to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:.

PRISMA Checklist. It contains the PRISMA Checklist.

Additional file 2:.

Search strategy. It contains the search strategies used.

Additional file 3:.

Data collection systems excluded. It contains the description of the excluded data collection systems.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berrueta, M., Ciapponi, A., Bardach, A. et al. Maternal and neonatal data collection systems in low- and middle-income countries for maternal vaccines active safety surveillance systems: A scoping review. BMC Pregnancy Childbirth 21, 217 (2021). https://doi.org/10.1186/s12884-021-03686-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12884-021-03686-9

Keywords

  • Active surveillance
  • Electronic Registries
  • Global Health
  • Health Information Systems
  • Pharmacovigilance
  • Pregnancy
  • Vaccination

BMC Pregnancy and Childbirth

ISSN: 1471-2393

Contact us